Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylation

Toxicol Appl Pharmacol. 2019 Sep 1:378:114606. doi: 10.1016/j.taap.2019.114606. Epub 2019 Jun 3.

Abstract

Inorganic arsenic is an environmental carcinogen that poses a major global public health risk. A high percentage of drinking water from wells in the U.S. contains higher-than-normal levels of arsenic, suggesting an increased risk of arsenic-induced deleterious effects. In addition to primary preventive measures, therapeutic strategies need to effectively address and integrate multiple molecular mechanisms underlying arsenic-induced carcinogenesis. We previously showed that the loss of miR-199a-5p in arsenic-transformed cells is pivotal to promote arsenic-induced angiogenesis and tumor growth in lung epithelial cells. In this study, we further showed that subacute or chronic exposure to arsenic diminished miR-199a-5p levels largely due to DNA methylation, which was achieved by increased DNA methyltransferase-1 (DNMT1) activity, mediated by the formation of specific protein 1 (Sp1)/DNMT1 complex. In addition to the DNA hypermethylation, arsenic exposure also repressed miR-199a transcription through a transcriptional repressor Sp1. We further identified an association between miR-199a-5p repression and the arsenic-mediated energy metabolic shift, as reflected by mitochondria defects and a switch to glycolysis, in which a glycolytic enzyme pyruvate kinase 2 (PKM2) was a functional target of miR-199a-5p. Taken together, the repression of miR-199a-5p through both Sp1-dependent DNA methylation and Sp1 transcriptional repression promotes an arsenic-mediated metabolic shift from mitochondria respiration to aerobic glycolysis via PKM2.

Keywords: Arsenic; DNA methylation; Glycolysis; PKM2; Sp1; miR-199a-5p.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Activation, Metabolic / drug effects
  • Arsenic / adverse effects*
  • Carcinogenesis / drug effects
  • Cell Line
  • DNA Methylation / drug effects*
  • Glycolysis / drug effects
  • Humans
  • MicroRNAs / genetics*
  • Sp1 Transcription Factor / genetics*

Substances

  • MicroRNAs
  • Sp1 Transcription Factor
  • SP1 protein, human
  • mirn199 microRNA, human
  • Arsenic